文献速递慢性肾脏病肾小球疾病遗传性与小管间质肾病

基因检测在早发性肾病中的临床效用:七个基因是主要致病基因

Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players.
PubMed 文献 · Nephrol Dial Transplant · 2022-01-01

该研究对460例疑似单基因病因的早发性慢性肾脏病(CKD)患者进行肾脏病基因panel二代测序及MUC1 c.428dupC靶向筛查,总体诊断率为65%(300/460),不同临床诊断组诊断率从38%至77%不等;在300例基因诊断患者中,7个基因(COL4A3、COL4A4、COL4A5、HNF1B、PKD1、PKD2和PKHD1)占66%(198/300)。

要点

  • 早发性CKD疑似单基因病因患者基因检测总体诊断率为65%。
  • 7个基因(COL4A3/4/5、HNF1B、PKD1/2、PKHD1)贡献66%的基因诊断。
  • 基因诊断可明确病因、助力遗传咨询并改善患者管理。

核心结论

  • 本队列中三分之二的早发性CKD患者存在遗传病因。
  • 仅7个基因解释了大多数基因诊断。
  • 建立遗传诊断对明确CKD精确病因至关重要,有助于准确遗传咨询和改善患者管理。

研究设计与样本

  • 对460例疑似单基因病因的早发性CKD患者进行定制肾脏病基因panel二代测序。
  • 同时进行MUC1 c.428dupC靶向筛查。

主要发现

  • 总体诊断率为65%(300/460)。
  • 囊性肾病诊断率77%,肾小管病76%,常染色体显性肾小管间质性肾病67%,肾小球病61%,先天性肾脏和尿路畸形38%。
  • 300例基因诊断患者中,77%临床诊断得到确认,15%在临床诊断组内获得特定诊断,7%被重新分类。
  • 共识别64个致病基因,其中7个基因(COL4A3、COL4A4、COL4A5、HNF1B、PKD1、PKD2和PKHD1)占基因诊断患者的66%(198/300)。

临床怎么用

  • 对早发性CKD疑似单基因病因患者应开展基因检测以明确病因。
  • 基因诊断可用于遗传咨询和指导患者管理。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Inherited kidney diseases are one of the leading causes of chronic kidney disease (CKD) that manifests before the age of 30 years. Precise clinical diagnosis of early-onset CKD is complicated due to the high phenotypic overlap, but genetic testing is a powerful diagnostic tool. We aimed to develop a genetic testing strategy to maximize the diagnostic yield for patients presenting with early-onset CKD and to determine the prevalence of the main causative genes. METHODS: We performed genetic testing of 460 patients with early-onset CKD of suspected monogenic cause using next-generation sequencing of a custom-designed kidney disease gene panel in addition to targeted screening for c.428dupC MUC1. RESULTS: We achieved a global diagnostic yield of 65% (300/460), which varied depending on the clinical diagnostic group: 77% in cystic kidney diseases, 76% in tubulopathies, 67% in autosomal dominant tubulointerstitial kidney disease, 61% in glomerulopathies and 38% in congenital anomalies of the kidney and urinary tract. Among the 300 genetically diagnosed patients, the clinical diagnosis was confirmed in 77%, a specific diagnosis within a clinical diagnostic group was identified in 15%, and 7% of cases were reclassified. Of the 64 causative genes identified in our cohort, 7 (COL4A3, COL4A4, COL4A5, HNF1B, PKD1, PKD2 and PKHD1) accounted for 66% (198/300) of the genetically diagnosed patients. CONCLUSIONS: Two-thirds of patients with early-onset CKD in this cohort had a genetic cause. Just seven genes were responsible for the majority of diagnoses. Establishing a genetic diagnosis is crucial to define the precise aetiology of CKD, which allows accurate genetic counselling and improved patient management.

来源:Nephrol Dial Transplant,查看原文。版权归原作者所有。

引用

  1. Domingo-Gallego A, Pybus M, Bullich G, et al. Clinical utility of genetic testing in early-onset kidney disease: seven genes are the main players. Nephrol Dial Transplant. 2022. PMID: 33532864. doi:10.1093/ndt/gfab019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。